Skip to main content

Helixgate

Skip to main content

Helixgate

Uncategorized

Large Bioprinted Tissues Get a Precision Boost

Published

on

Improving the cultivation of large bioprinted tissues could help make laboratory-grown tissue models more reliable for drug development and regenerative medicine. At the International Society for Cell & Gene Therapy (ISCT) 2026 annual meeting in Dublin, Elliot Cowles, a doctoral student in bioprocess engineering at Université Claude Bernard Lyon, and colleagues presented a perfusion-based culture system, which was described in Cytotherapy, that addresses this challenge. Although biofabricated tissues are increasingly used for in vitro research, many remain relatively small and are typically grown under static conditions that limit scalability and consistency.

The team’s approach combines custom-designed, 3D-printed components with an Ambr250 bioreactor to maintain tightly regulated culture conditions. The researchers validated the custom parts as autoclavable and leak-proof before using them to support an 8-cm2 macroporous bioprinted tissue. Culture medium was continuously pumped through the tissue at 1.5 mL/min while the bioreactor regulated oxygen levels, temperature, and pH.

To better understand what was happening inside the tissue without damaging it, the researchers used high-resolution magnetic resonance imaging. The scans reconstructed the tissue’s three-dimensional structure and tracked how fluid moved through it. Rather than flowing uniformly, the liquid followed uneven pathways that differed from computer-aided design predictions, revealing a more complex internal environment than expected.

Over a 21-day culture period with this platform, temperature, dissolved oxygen, and pH remained stable across a broad range of oxygen settings. The team did detect a consistent difference between oxygen levels measured in the regulation vessel and those reaching the tissue chamber, but traced the discrepancy to oxygen entering the culture medium through flexible tubing. Still, the researchers successfully perfused three large mesenchymal stem cell–based tissues using minimal culture medium.

Cowles and his colleagues concluded that the new platform provides a controlled environment for cultivating larger bioprinted tissues while offering detailed, non-destructive monitoring of internal flow patterns. Looking ahead, they plan to improve quantitative flow measurements and develop computational fluid dynamics models capable of mapping local tissue microenvironments, with the goal of advancing reproducible large-scale tissue maturation.

The post Large Bioprinted Tissues Get a Precision Boost appeared first on GEN – Genetic Engineering and Biotechnology News.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Uncategorized

New webinar: Tackling drug discovery challenges in cancer research

Published

on

Cancer cells

Hosted by Drug Discovery World and supported by Sartorius and BioIVT, this webinar will explore the opportunities and challenges that exist within cancer research drug discovery and development.

You will hear from Dr Sudha Rao, Chief Scientific Officer of Kazia Therapeutics, Karol Budzik, PhD, Business Development Associate at Vyriad Therapeutics and Lars van der Veen, Chief Scientific Officer at iOnctura.

Presentations will cover how cancer treatments have shifted towards reprogramming the biology driving tumour growth, immune escape and treatment resistance, the trajectory that in vivo CAR-T treatments are taking, and how challenging tumours burdened by stroma and immune-mediated resistance can be tackled.

Q&A with the speakers follows the presentations.

Register for free now.

The post New webinar: Tackling drug discovery challenges in cancer research appeared first on Drug Discovery World (DDW).

Continue Reading

Uncategorized

Psilocybin proves promising in neuropathic pain mouse study

Published

on

Amid the rise of psychedelics in the mental health space, researchers have begun to explore psilocybin as a treatment for chemotherapy-induced peripheral neuropathy.

Continue Reading

Uncategorized

New Spectrometry Technique Could Aid Formulation Development

New Spectrometry Technique Could Aid Formulation Development

Published

on

A new technique combining two forms of spectrometry could help biopharmaceutical companies improve their choice of formulation buffer for antibody manufacturing by revealing how molecular forms and three-dimensional shapes of complex biologics respond to their environment. That’s the view of Christian Bleiholder, PhD, a professor at Florida State University who helped develop the technique.

According to Bleiholder, what happens structurally when a complex biological molecule, such as an antibody or viral spike protein, binds to its target is currently poorly understood.

“This is where [this approach] can help with the bioprocessing and formulation,” he says, as structural changes “can affect the lifespan [of the product] and lead to issues, such as aggregation.”

Because antibodies are complex, existing techniques tend to be powerful at different levels of complexity, he explains. Mass spectrometry is particularly powerful for distinguishing molecular composition, while structural approaches such as X-ray crystallography and cryo-electron microscopy can provide high-resolution structural information.

The challenge is understanding the link between these things within a heterogeneous sample, he says.

To overcome this, Bleiholder and his team worked with Bruker Daltonics to develop Tandem-Trapped Ion Mobility Spectrometry (Tandem-TIMS). This combines tandem ion mobility spectrometry with tandem mass spectrometry to disentangle three overlapping layers of molecular complexity: molecular form, three-dimensional shape, and binding or assembly state, he says.

He explains that, if the proteins have different structures, they can be characterized with tandem ion mobility spectrometry, and then mass spectrometry can be used to look at their molecular forms and binding states.

Going forward, Bleiholder hopes the technique can be used for formulation development but also earlier, during drug discovery of new products, such as multi-specific antibodies, to determine which molecular states are important and how those change when a biologic engages its target. He also plans to look at automating the technique.

Bleiholder spoke about using Tandem-TIMS at the Bioprocessing Summit in Boston earlier this year.

The post New Spectrometry Technique Could Aid Formulation Development appeared first on GEN – Genetic Engineering and Biotechnology News.

Continue Reading

Trending

Helixgate Biotech Review July Issue QR CodeScan to Read